The mir-21 Inhibition Enhanced HUVEC Cellular Viability during Hypoxia-Reoxygenation Injury by Regulating PDCD4

<div>ROC curve analysis was used for categorizing the severity of CAD patients: (a) healthy controls and single-vessel lesion CAD (AUC 0.893); (b) dual-vessel stenosis CAD with healthy subjects (AUC 0.914); (c) healthy volunteers and multivessel blocked CAD patients (AUC 0.933).</div>

Mediators of Inflammation

fig2

Figure 2

Figure 2: The mir-21 Inhibition Enhanced HUVEC Cellular Viability during Hypoxia-Reoxygenation Injury by Regulating PDCD4 